[Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].
作者信息
Assumma M, Russo V, Alemanno A
出版信息
Arch Ital Sci Med Trop Parassitol. 1967 Jul-Aug;48(7):175-86.
PMID:5615073
Abstract
摘要
相似文献
1
[Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].[使用萨宾口服脊髓灰质炎疫苗完成一个免疫周期一年后的抗体状态]
Arch Ital Sci Med Trop Parassitol. 1967 Jul-Aug;48(7):175-86.
2
[Research on the administration of Mexaform in the course of anti-poliomyelitis vaccination with Sabin's attenuated virus].[在使用萨宾减毒病毒进行抗脊髓灰质炎疫苗接种过程中使用美沙芬的研究]
Minerva Med. 1967 Apr 25;58(33):1497-502.
3
[Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
Schweiz Med Wochenschr. 1969 Sep 13;99(37):1322-4.
4
Poliomyelitis vaccination in Thailand. I. A pilot study of the administration of live poliomyelitis vaccine.泰国的脊髓灰质炎疫苗接种。一、口服脊髓灰质炎活疫苗的试点研究。
Southeast Asian J Trop Med Public Health. 1974 Jun;5(2):171-8.
5
Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus.扁桃体切除术和腺样体切除术对鼻咽部脊髓灰质炎病毒抗体反应的影响。
N Engl J Med. 1971 Jan 14;284(2):59-64. doi: 10.1056/NEJM197101142840201.
6
7
[Place of antipoliomyelitic vaccination in a vaccination schedule for mass use in Africa].[抗脊髓灰质炎疫苗在非洲大规模使用的疫苗接种计划中的地位]
Med Trop (Mars). 1970 Nov-Dec;30(6):829-36.
8
Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.在大规模疫苗接种运动与常规免疫规划中口服脊髓灰质炎疫苗的免疫原性。
Bull World Health Organ. 1995;73(6):769-77.
9
[Poliomyelitis immunization].[脊髓灰质炎免疫接种]
Landarzt. 1967 May 31;43(15):716-20.
10
[Will Salk's polio vaccination be used again?].[索尔克的脊髓灰质炎疫苗会再次被使用吗？]
Fortschr Med. 1978 Apr 6;96(13):688-94.
Zotero 插件